机构:[1]Department of pathology, Taizhou Hospital, Wenzhou Medical University, Linhai, Zhejiang Province, 317000, China.台州恩泽医疗中心台州医院[2]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, China四川大学华西医院[3]Department of pathology, Taizhou Hospital, Wenzhou Medical University, Linhai, Zhejiang Province, 317000, China台州恩泽医疗中心台州医院
第一作者机构:[1]Department of pathology, Taizhou Hospital, Wenzhou Medical University, Linhai, Zhejiang Province, 317000, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Ye Lu-Xia,Yu Qing-Xin,Li Deng-Xiong,et al.The prognostic value of Secretogranin II and its impact on the immune microenvironment in patients with renal-cell carcinoma[J].ASIAN JOURNAL OF SURGERY.2023,46(9):4033-4035.doi:10.1016/j.asjsur.2023.04.043.
APA:
Ye Lu-Xia,Yu Qing-Xin,Li Deng-Xiong&Wang Qiu-Peng.(2023).The prognostic value of Secretogranin II and its impact on the immune microenvironment in patients with renal-cell carcinoma.ASIAN JOURNAL OF SURGERY,46,(9)
MLA:
Ye Lu-Xia,et al."The prognostic value of Secretogranin II and its impact on the immune microenvironment in patients with renal-cell carcinoma".ASIAN JOURNAL OF SURGERY 46..9(2023):4033-4035